| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $427.5M | $379.8M | $306.6M |
| YoY Revenue Growth % | +12.6% | +23.9% | — |
| Gross Profit | $122.1M | $119.6M | — |
| Gross Margin % | 28.6% | 31.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $7.0M | -$116.1M | -$106.7M |
| Operating Margin % | 1.6% | -30.6% | -34.8% |
| Net Income (GAAP) | -$29.0M | -$195.0M | -$106.0M |
| EBITDA (Normalized) | $22.9M | -$93.9M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $75.9M | $2.8M | -$75.3M |
| Capital Expenditures (CapEx) | $19.8M | $27.7M | — |
| Free Cash Flow (FCF) | $56.1M | -$24.9M | -$75.3M |
| FCF Margin % | 13.1% | -6.6% | -24.6% |
| Return on Invested Capital (ROIC %) | 1.8% | -29.1% | — |
| Cash & Short-Term Equivalents | $105.0M | $73.0M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $410.5M | $387.9M | — |